Socioeconomic disparities in the decline in invasive breast cancer incidence

Breast Cancer Research and Treatment

Volumn 122, Issue 3, 2010, Pages 873-878

  Sprague, Brian L ^a   Trentham Dietz, Amy ^a,b   Burnside, Elizabeth S ^a,c  

^a UNIVERSITY OF WISCONSIN   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Breast neoplasms; Ductal carcinoma in situ; Epidemiology; Incidence; Mammography screening

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AGE DISTRIBUTION; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER INVASION; CANCER SCREENING; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; HUMAN; INCOME; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL; SOCIAL STATUS; SOCIOECONOMICS; ADOLESCENT; BREAST NEOPLASMS; CANCER REGISTRY; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HEALTH CARE DISPARITY; INCIDENCE; PATHOLOGY; PROGNOSIS; TUMOR INVASION; UNITED STATES; UTILIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HEALTHCARE DISPARITIES; HUMANS; INCIDENCE; MAMMOGRAPHY; NEOPLASM INVASIVENESS; PROGNOSIS; SEER PROGRAM; SOCIOECONOMIC FACTORS; UNITED STATES; YOUNG ADULT;

EID: 77955559704     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-0737-y     Document Type: Article

References (30)

1. PM Ravdin KA Cronin N Howlader, et al. 2007 The decrease in breast-cancer incidence in 2003 in the United States N Engl J Med 356 16 1670 1674 10.1056/NEJMsr070105 1:CAS:528:DC%2BD2sXksFCltL0%3D 17442911 (Pubitemid 46631679)
2. Horner MJ, Ries LAG, Krapcho M et al (2009) SEER Cancer Statistics Review, 1975-2006. National Cancer Institute, Bethesda. Based on November 2008 SEER data submission, posted to the SEER web site http://seer.cancer.gov/csr/ 1975-2006/
3. Collaborative Group on Hormonal Factors in Breast Cancer (1997) Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 350(9084):1047-1059
4. JE Rossouw GL Anderson RL Prentice, et al. 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 3 321 333 10.1001/jama.288.3.321 1:CAS:528:DC%2BD38Xltlegs7k%3D 12117397
5. RK Ross A Paganini-Hill PC Wan MC Pike 2000 Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin J Natl Cancer Inst 92 4 328 332 10.1093/jnci/92.4.328 1:CAS:528:DC%2BD3cXhsVGqtrs%3D 10675382
6. EB Claus M Stowe D Carter 2001 Breast carcinoma in situ: risk factors and screening patterns J Natl Cancer Inst 93 23 1811 1817 10.1093/jnci/93.23.1811 1:STN:280:DC%2BD3MnovVGgsw%3D%3D 11734598
7. GK Reeves V Beral J Green T Gathani D Bull 2006 Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis Lancet Oncol 7 11 910 918 10.1016/S1470-2045(06)70911-1 1:CAS:528:DC%2BD28XhtFKmt7bN 17081916 (Pubitemid 44615945)
8. CI Li JR Daling 2007 Changes in breast cancer incidence rates in the United States by histologic subtype and race/ethnicity, 1995 to 2004 Cancer Epidemiol Biomarkers Prev 16 12 2773 2780 10.1158/1055-9965.EPI-07-0546 18086787 (Pubitemid 351196336)
9. Wei F, Miglioretti DL, Connelly MT et al (2005) Changes in women's use of hormones after the Women's Health Initiative estrogen and progestin trial by race, education, and income. J Natl Cancer Inst Monogr 35:106-112
10. A Jemal E Ward MJ Thun 2007 Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women Breast Cancer Res 9 3 R28 10.1186/bcr1672 17477859 (Pubitemid 350214681)
11. BA Miller EJ Feuer BF Hankey 1993 Recent incidence trends for breast cancer in women and the relevance of early detection: an update CA Cancer J Clin 43 1 27 41 10.3322/canjclin.43.1.27 1:STN:280:DyaK3s7jslWjuw%3D%3D 8422603
12. PA Newcomb PM Lantz 1993 Recent trends in breast cancer incidence, mortality, and mammography Breast Cancer Res Treat 28 2 97 106 10.1007/BF00666422 1:STN:280:DyaK2c3islansA%3D%3D 8173073
13. N Breen K AC HI Meissner, et al. 2007 Reported drop in mammography: is this cause for concern? Cancer 109 12 2405 2409 10.1002/cncr.22723 17503429 (Pubitemid 46906458)
14. Morrison AS (1992) Screening in chronic disease, vol 19, 2nd edn. Oxford University Press, New York
15. BF Hankey EJ Feuer LX Clegg, et al. 1999 Cancer surveillance series: interpreting trends in prostate cancer-part I: evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates J Natl Cancer Inst 91 12 1017 1024 10.1093/jnci/91.12.1017 1:STN:280: DyaK1Mzgs1KgsA%3D%3D 10379964
16. Surveillance Epidemiology and End Results (SEER) Program. SEER Stat Database (released April 2009, based on the November 2008 submission). www.seer.cancer.gov
17. Fritz A, Percy C, Jack A et al (eds) (2000) International classification of diseases for oncology, 3rd edn. World Health Organization, Geneva
18. National Center for Health Statistics (2008) Health, United States, 2008 with chartbook. National Center for Health Statistics, Hyattsville
19. Ernster VL, Barclay J (1997) Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma. J Natl Cancer Inst Monogr 22:151-156
20. VL Ernster J Barclay K Kerlikowske D Grady C Henderson 1996 Incidence of and treatment for ductal carcinoma in situ of the breast JAMA 275 12 913 918 10.1001/jama.275.12.913 1:STN:280:DyaK287nvVOmtA%3D%3D 8598618 (Pubitemid 26095381)
21. SS Devesa EL Diamond 1980 Association of breast cancer and cervical cancer incidence with income and education among whites and blacks J Natl Cancer Inst 65 3 515 528 1:STN:280:DyaL3M%2FhtVCgtw%3D%3D 6931932
22. SA Robert I Strombom A Trentham-Dietz, et al. 2004 Socioeconomic risk factors for breast cancer: distinguishing individual- and community-level effects Epidemiology 15 4 442 450 10.1097/01.ede.0000129512.61698.03 15232405 (Pubitemid 40416932)
23. SJ Katz JK Zemencuk TP Hofer 2000 Breast cancer screening in the United States and Canada, 1994: socioeconomic gradients persist Am J Public Health 90 5 799 803 10.2105/AJPH.90.5.799 1:STN:280:DC%2BD3c3mtVahuw%3D%3D 10800435
24. KE Heck ER Pamuk 1997 Explaining the relation between education and postmenopausal breast cancer Am J Epidemiol 145 4 366 372 1:STN:280: DyaK2s7ovVKrtQ%3D%3D 9054241
25. D Friedman-Koss CJ Crespo MF Bellantoni RE Andersen 2002 The relationship of race/ethnicity and social class to hormone replacement therapy: results from the Third National Health and Nutrition Examination Survey 1988-1994 Menopause 9 4 264 272 10.1097/00042192-200207000-00007 12082362
26. NF Marks DS Shinberg 1998 Socioeconomic status differences in hormone therapy Am J Epidemiol 148 6 581 593 1:STN:280:DyaK1cvitl2gtw%3D%3D 9753013
27. K Kerlikowske DL Miglioretti R Ballard-Barbash, et al. 2003 Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population J Clin Oncol 21 23 4314 4321 10.1200/JCO.2003.05.151 1:CAS:528:DC%2BD2cXpsVWqu7g%3D 14645420 (Pubitemid 46621806)
28. K Kerlikowske DSM Buist R Walker 2007 Author reply: declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population JNCI 99 23 1816 1817 (Pubitemid 351767203)
29. A Trentham-Dietz PA Newcomb BE Storer PL Remington 2000 Risk factors for carcinoma in situ of the breast Cancer Epidemiol Biomarkers Prev 9 7 697 703 1:STN:280:DC%2BD3M%2FmvVygtQ%3D%3D 10919740
30. Clarke LD, Plevritis SK, Boer R, Cronin KA, Feuer EJ (2006) A comparative review of CISNET breast models used to analyze U.S. breast cancer incidence and mortality trends. J Natl Cancer Inst Monogr 36:96-105